Cancer Biology & Genetics Program
The Joan Massagué Lab
Research
We are interested in metastasis, the cause of 90% of cancer deaths. The lab investigates metastatic stem cells and their stromal niches. The role of immune regulatory and regenerative signals, particularly TGF-β, is of interest. General as well as organ-specific mediators of metastasis are under investigation. We are defining the phenotypic plasticity and evolution of metastatic cell populations from dormancy to outbreak, identifying drug targets, and enabling clinical trials to treat metastasis.
Featured News
Publications Highlights
Lee JH, Sánchez-Rivera FJ, He L, Basnet H, Chen F, Spina E, Li L, Torner C, Chan JE, Yarlagadda DVK, Park JS, Sussman C, Rudin CM, Lowe SW, Tammela T, Macias MJ, Koche RP, Massagué J. TGF-β and RAS jointly unmask primed enhancers to drive metastasis. Cell (2024) Oct 31;187(22):6182-6199.e29. DOI: 10.1016/j.cell.2024.08.014 PMID: 39243762 PMCID: PMC12035776
People
Joan Massagué, PhD
Director, Sloan Kettering Institute; Marie-Josée and Henry R. Kravis Chair; Member, Cancer Biology & Genetics Program
- Joan Massagué studies the control of stem cell growth and phenotype in tumor progression, metastasis, and response to therapy.
- PhD, University of Barcelona
- massaguj@mskcc.org
- Email Address
- 646-888-2044
- Office Phone
Members
- BS, Peking University (Physics)
- PhD, Harvard University (Systems Biology
- 646-888-2063
- Lab Phone
- BS, Massachusetts Institute of Technology
- BS, Bilkent Universitesi
- Cornell/Sloan Kettering Graduate School
- Binghamton University
- Cornell/Sloan Kettering Graduate School
- Cornell/Sloan Kettering Graduate School
- U. Med Sciences Beijing
- Roswell Park Cancer Institute, NY
- University of Barcelona
- Rockefeller/Cornell/Sloan Kettering
- Rockefeller University
- University of Turku, Finland
- University of Rome
- Cornell/Sloan Kettering Graduate School
- Duke University
- Cornell University, Ithaca
- University of Helsinki, Finland
- Cornell/Sloan Kettering Graduate School
- Rockefeller/Cornell/Sloan Kettering
- Wesleyan University
- University of Texas, Austin
- University of Rochester
- Medical University of Graz, Austria
- ISREC
- Rockefeller Cornell/Sloan Kettering
- 1987, University of Santiago, Spain
- Cornell/Sloan Kettering Graduate School
- Uppsala University
- University of Barcelona
- University of Barcelona, Spain
- McMaster University, Ontario, Canada
- Harvard Medical School
- Institute of Neuroscience, Alicante, Spain
- University of Helsinki, Finland
- Cornell/Sloan Kettering Graduate School
- University of York
- University of Toronto
- New York University, New York
- London Research Institute
- Columbia University, New York
- Tsinghua University
Achievements
- Chief Scientific Officer, MSKCC (2023–2025)
- Director, Sloan Kettering Institute (2014–)
- HHMI Scientific Review Board (2014–2025)
- HHMI Investigator (1990-2013)
- Fellow, American Association for Cancer Research (AACR) Academy (2016)
- Pezcoller Foundation-AACR International Award for Cancer Research (2016)
- Charles Rodolphe Brupbacher Prize for Cancer Research (2015)
- National Prize for Research in Biology, Spain (2014)
- American Italian Cancer Foundation Price (2013)
- Prize in Cancer Research, Robert J. and Claire Pasarow Foundation (2011)
- Frontiers Prize in Biomedicine, BBVA Foundation (2008)
- Vilcek Prize, Vilcek Foundation (2006)
- Member, Institute of Medicine (2006)
- Award in Science and Technology, Prince Asturius Foundation (2004)
- Member, National Academy of Sciences (2000)
- Member, American Academy of Arts and Sciences (1999)
- Investigator, Howard Hughes Medical Institute (1990)
- Elucidation of the TGF-beta pathway
Lab News & Events
Open Positions
To learn more about available postdoctoral opportunities, please visit our Career Center
To learn more about compensation and benefits for postdoctoral researchers at MSK, please visit Resources for Postdocs
Post Doctoral Position
Get in Touch
-
Lab Head Email
-
Office Phone
-
Lab Phone
Disclosures
Members of the MSK Community often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community. These activities outside of MSK further our mission, provide productive collaborations, and promote the practical application of scientific discoveries.
MSK requires doctors, faculty members, and leaders to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public. Not all disclosed interests and relationships present conflicts of interest. MSK reviews all disclosed interests and relationships to assess whether a conflict of interest exists and whether formal COI management is needed.
Joan Massagué discloses the following relationships and financial interests:
-
Institute for Research in Biomedicine Barcelona
Professional Services and Activities
-
Scholar Rock
Equity
The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2024 through disclosure submission in spring 2025). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at ecoi@mskcc.org.